New clinical evidence from the European tobramycin trial in cystic fibrosis

Journal of Cystic Fibrosis

Volumn 1, Issue , 2002, Pages 199-202

  Hodson, M E ^a   Gallagher, C G ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Airways reactivity; Cystic fibrosis; Pseudomonas aeruginosa; TOBI; Tobramycin

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; COLISTIMETHATE; COLISTIN; TOBRAMYCIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHRONIC DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTIC FIBROSIS; DENSITY GRADIENT; DISEASE EXACERBATION; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; EUROPE; FORCED EXPIRATORY VOLUME; GRAM NEGATIVE INFECTION; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG DISEASE; LUNG FIBROSIS; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MORBIDITY; MORTALITY; MULTICENTER STUDY; NEBULIZATION; NEBULIZER; OPEN STUDY; PHARYNGITIS; PSEUDOMONAS AERUGINOSA; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; SPUTUM LEVEL; TREATMENT OUTCOME; UNITED STATES;

ADMINISTRATION, INHALATION; ANTI-BACTERIAL AGENTS; COLISTIN; CYSTIC FIBROSIS; EUROPE; HUMANS; LUNG DISEASES; NEBULIZERS AND VAPORIZERS; PSEUDOMONAS INFECTIONS; RANDOMIZED CONTROLLED TRIALS; RESPIRATORY FUNCTION TESTS; TOBRAMYCIN; TREATMENT OUTCOME;

EID: 0036889603     PISSN: 15691993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1569-1993(02)00004-8     Document Type: Article

References (7)

1. Penketh ARL, Wise A, Mearns MB, Hodson ME, Batten JC. Cystic fibrosis in adolescents and adults. Thorax 1987;42:526-32.
2. Ramsey BW, Pepe MS, Quan JM, et al. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. N Engl J Med 1999;340:23-30.
3. Ramsey BW, et al. Long-term efficacy and safety of inhaled tobramycin (TOBI) in patients with cystic fibrosis. Proceedings of the 12th Annual North American Cystic Fibrosis Conference 1998, Montreal, Canada. 1998.
4. Ramsey BW, et al. Survival and lung function during two years of treatment with intermittent tobramycin solution for inhalation in CF patients. Abstract from 23rd European Cystic Fibrosis Conference 1999, The Hague, Netherlands. 1999.
5. Frederiksen B, Koch C, Hoiby N. Antibiotic treatment of initial colonisation with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis. Pediatr Pulmonol 1997;23:330-5.
6. Hodson ME, Gallagher CG, Govan JRW. A randomised trial of nebulized tobramycin or colistin in cystic fibrosis. European Respiratory Journal 2002;20:658-64.
7. Jensen T, Pedersen SS, Garne S, Heilmann C, Hoiby N, Koch C. Colistin inhalation therapy in cystic fibrosis patients with chronic Pseudomonas aeruginosa lung function. J Antimicrob Chemother 1987;19:831-8.